• Skip to main content
  • Skip to footer

EydisBio

  • About Us
  • Technology
    • Pipeline
  • Therapeutic indications
    • Rheumatoid Arthritis
    • Chronic Pain
    • COVID-19 ARDS
  • Our Team
  • Resources
    • Publications & Press Releases
    • FCOI
    • Partners & Funders
  • Contact

About EydisBio

The mission behind our company

Our mission is to leverage our unique platform technology and expertise to discover and develop novel small molecule therapies aimed at addressing serious unmet medical needs for patients suffering from autoimmune and inflammatory diseases.

Contact Us

Our Difference

Decades of experience

Decades of experience
across several industries

Development of selective and potent kinase inhibitors

Development of
selective and potent
kinase inhibitors

Collaborative approach

Collaborative approach
to drug development

Impact
Our Impact

EydisBio is the first group to develop a highly selective,
orally bioavailable TAK1 inhibitor for the treatment of
autoimmune and inflammatory diseases. Utilizing our
highly innovative chemistry platform, we pride ourselves
on our ability to develop highly selective kinase inhibitors
towards various diseases.

Explore our technology

Timothy Haystead,
PhD: President & Founder

“Protein kinases are generally recognized as valuable drug targets because of their roles in many human diseases. Yet, very few drugs targeting protein kinases have successfully made it through clinical trials.

Targeting genome-expressed protein kinases is incredibly difficult. The genome expresses over 450 distinct protein kinases, as well as over 2,000 other non-related proteins with similar ATP-binding properties to protein kinases.

Read more

EydisBio is currently developing a series of highly selective protein kinase inhibitors. Using our Universial Purinome Capture Platform (UPCP), a unique chemoproteomics platform that can define novel chemical scaffolds, EydisBio can identify the protein kinase of interest against the myriad of other proteins. We believe that dialing out off-target liabilities early in the discovery process leads to both better therapeutic outcomes and higher developmental success rates.

Currently, EydisBio is focused on targets involved in autoimmune and inflammatory diseases, as well as various immune-related cancers.”

Colored Bio Img
Meet our team of experts

EydisBio is an industry-leading biotech comprised of outstanding scientists, business advisors, and financial consultants. We are dedicated to creating solutions for unmet medical needs through autoimmune and inflammatory drug discovery, preclinical development, and purine-based small molecule compound development.

Learn more about our team

Team
Partner with us

Interested in learning more about how you can partner
with EydisBio? Contact our team below

Partner

"*" indicates required fields

GDPR Consent*
This field is for validation purposes and should be left unchanged.

Footer Logo

201 W Main Street, Suite #317, Durham, NC, 27701
Privacy Policy | Web Accessibility. Design by TinyFrog Technologies

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits.
By clicking “Accept”, you consent to the use of ALL the cookies. AcceptReject
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT